Basel Medical Group Statistics
Total Valuation
BMGL has a market cap or net worth of $1.08 million. The enterprise value is $8.11 million.
| Market Cap | 1.08M |
| Enterprise Value | 8.11M |
Important Dates
The last earnings date was Friday, June 26, 2026, before market open.
| Earnings Date | Jun 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BMGL has 1.58 million shares outstanding. The number of shares has increased by 1.06% in one year.
| Current Share Class | 1.58M |
| Shares Outstanding | 1.58M |
| Shares Change (YoY) | +1.06% |
| Shares Change (QoQ) | -11.89% |
| Owned by Insiders (%) | 13.50% |
| Owned by Institutions (%) | 0.07% |
| Float | 518,049 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | n/a |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 2.12.
| Current Ratio | 1.23 |
| Quick Ratio | 1.10 |
| Debt / Equity | 2.12 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | n/a |
| Interest Coverage | -1.72 |
Financial Efficiency
Return on equity (ROE) is -28.66% and return on invested capital (ROIC) is -5.80%.
| Return on Equity (ROE) | -28.66% |
| Return on Assets (ROA) | -2.71% |
| Return on Invested Capital (ROIC) | -5.80% |
| Return on Capital Employed (ROCE) | -9.97% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $202,728 |
| Profits Per Employee | -$7,049 |
| Employee Count | 82 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 36.59 |
Taxes
In the past 12 months, BMGL has paid $138,755 in taxes.
| Income Tax | 138,755 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.09% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -96.09% |
| 50-Day Moving Average | 4.25 |
| 200-Day Moving Average | 6.39 |
| Relative Strength Index (RSI) | 19.18 |
| Average Volume (20 Days) | 2,348,684 |
Short Selling Information
The latest short interest is 12,972, so 0.82% of the outstanding shares have been sold short.
| Short Interest | 12,972 |
| Short Previous Month | 11,310 |
| Short % of Shares Out | 0.82% |
| Short % of Float | 2.50% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, BMGL had revenue of $16.62 million and -$578,008 in losses. Loss per share was -$0.60.
| Revenue | 16.62M |
| Gross Profit | 6.44M |
| Operating Income | -610,857 |
| Pretax Income | -965,801 |
| Net Income | -578,008 |
| EBITDA | -339,878 |
| EBIT | -610,857 |
| Loss Per Share | -$0.60 |
Balance Sheet
The company has $409,467 in cash and $7.43 million in debt, with a net cash position of -$7.02 million or -$4.44 per share.
| Cash & Cash Equivalents | 409,467 |
| Total Debt | 7.43M |
| Net Cash | -7.02M |
| Net Cash Per Share | -$4.44 |
| Equity (Book Value) | 3.51M |
| Book Value Per Share | 2.44 |
| Working Capital | 1.75M |
Cash Flow
In the last 12 months, operating cash flow was -$494,390 and capital expenditures -$193,203, giving a free cash flow of -$687,593.
| Operating Cash Flow | -494,390 |
| Capital Expenditures | -193,203 |
| Depreciation & Amortization | 272,932 |
| Net Borrowing | -1.38M |
| Free Cash Flow | -687,593 |
| FCF Per Share | -$0.43 |
Margins
Gross margin is 38.77%, with operating and profit margins of -3.67% and -3.48%.
| Gross Margin | 38.77% |
| Operating Margin | -3.67% |
| Pretax Margin | -5.81% |
| Profit Margin | -3.48% |
| EBITDA Margin | -2.04% |
| EBIT Margin | -3.67% |
| FCF Margin | n/a |
Dividends & Yields
BMGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.06% |
| Shareholder Yield | -1.06% |
| Earnings Yield | -88.12% |
| FCF Yield | -68.41% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 22, 2026. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 22, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |